Results 111 to 120 of about 38,001 (122)
Some of the next articles are maybe not open access.

Memantine Blocks α7* Nicotinic Acetylcholine Receptors More Potently Than N-Methyl-D-aspartate Receptors in Rat Hippocampal Neurons

Journal of Pharmacology and Experimental Therapeutics, 2005
The N-methyl-d-aspartate (NMDA) receptor antagonist memantine is an approved drug for treatment of Alzheimer's disease (AD). Other such treatments are cholinesterase inhibitors and nicotinic acetylcholine receptor (nAChR)-sensitizing agents such as ...
Y. Aracava   +3 more
semanticscholar   +1 more source

Role of peripheral N-methyl-D-aspartate (NMDA) receptors in visceral nociception in rats.

Gastroenterology, 2001
BACKGROUND & AIMS N-methyl-D-aspartate (NMDA) receptors are ligand-gated ion channels that have an important role in long-term potentiation and memory processing in the central nervous system.
J. McRoberts   +13 more
semanticscholar   +1 more source

Channel blockers acting at N-methyl-D-aspartate receptors: differential effects of mutations in the vestibule and ion channel pore.

Molecular Pharmacology, 2002
A large number of structurally diverse compounds act as open-channel blockers of NMDA receptors. They may share discrete or overlapping binding sites within the channel. In this study, the effects of mutations in and around the membrane-spanning and pore-
K. Kashiwagi   +6 more
semanticscholar   +1 more source

Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro.

Journal of Pharmacology and Experimental Therapeutics, 1997
G. Fischer   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy